The US Federal Trade Commission filed a lawsuit on Friday aimed at stopping the $1.9 billion merger of medical technology provider Steris Corp and British sterilization services provider Synergy Health, according to the agency, which enforces antitrust law.
Synergy Health and Steris, both of which provide contract sterilization services using radiation for medical devices, said they would fight the FTC and that they were confident they would prevail.
“We are very disappointed by the FTC’s decision to impede this transaction and intend to vigorously challenge their claims in court,” Synergy Health Chief Executive Richard Steeves said in a statement.
The FTC said that the deal would hurt Synergy’s and Steris’ customers by eliminating “likely future competition between Steris’s gamma sterilization facilities and Synergy’s planned x-ray sterilization facilities in the United States.”
This deal is one of several inversion deals in which US companies seek to reincorporate overseas to get lower tax rates.
Full content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Apple Faces Contempt Hearings Over App Store Reforms
May 19, 2024 by
CPI
T-Mobile Faces Class-Action Lawsuit Over Sprint Merger After Appeal Denied
May 16, 2024 by
CPI
Google Faces Backlash Over Introduction of AI-Generated Summaries in Searches
May 16, 2024 by
CPI
CMA Launches Phase 2 Probe into AlphaTheta’s Acquisition of Serato
May 16, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI